Methylenetetrahydrofolate Reductase 677 C → T Mutation and Coronary Heart Disease Risk in UK Indian Asians
- 1 November 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 20 (11) , 2448-2452
- https://doi.org/10.1161/01.atv.20.11.2448
Abstract
—Plasma homocysteine concentrations are elevated in UK Indian Asians and may contribute to twice as many coronary heart disease (CHD) deaths in this group compared with European whites. The mechanisms underlying elevated homocysteine concentrations among Indian Asians are not well understood. In this study, we have investigated the extent to which the methylenetetrahydrofolate reductase (MTHFR) 677 C → T mutation accounts for elevated plasma homocysteine and increased CHD risk in Indian Asians compared with European whites. We investigated 454 male cases (with myocardial infarction or angiographically proven CHD: 224 Indian Asians, 230 European whites) and 805 healthy male controls (381 Indian Asians, 424 European whites). Fasting homocysteine concentrations, MTHFR 677 C → T genotype, and conventional CHD risk factors were measured. The prevalence of homozygous MTHFR 677 T in Indian Asian controls was less than one third that in European white controls (3.1% versus 9.7%, P 15 μmol/L). In contrast, among European whites, the TT MTHFR genotype was strongly related to elevated plasma homocysteine concentrations and was found in 27% of the European controls with hyperhomocysteinemia. Elevated homocysteine in Indian Asian compared with European white controls was accounted for by their reduced levels of B vitamins but not by the MTHFR 677 T genotype. However, neither the TT MTHFR genotype nor B vitamin levels explained the elevated homocysteine concentrations in CHD cases compared with controls. TT MTHFR was not a risk factor for early-onset CHD in Indian Asians (odds ratio, 0.5; 95% confidence interval, 0.1 to 2.4; P =0.39), unlike in European whites (odds ratio, 2.1; 95% confidence interval, 1.1 to 4.1; P =0.02). We conclude that the MTHFR 677 T mutation does not contribute to elevated plasma homocysteine concentrations or increased CHD risk in Indian Asians compared with European whites. Our results suggest that novel genetic defects and/or environmental factors influence homocysteine metabolism in Indian Asians residing in the United Kingdom.Keywords
This publication has 14 references indexed in Scilit:
- Homocysteine and vascular diseaseThe Lancet, 1999
- MTHFR association with arteriosclerotic vascular disease?Human Genetics, 1998
- C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populationsAtherosclerosis, 1998
- Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1997
- Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study.Journal of Clinical Investigation, 1996
- Molecular variant of 5,10-methylenetetrahydrofolate reductase is a risk factor of ischemic heart disease in the Japanese populationAtherosclerosis, 1996
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South AsiansThe Lancet, 1991